Sinus Dilation Devices Market Size And Share Report, 2027

The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market’s expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons.

Download PDF Brochure:

Key Market Drivers

  • Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices.
  • Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in demand for sinus dilation procedures.
  • Technological Advancements: Ongoing advancements in sinus dilation devices, such as better imaging capabilities and minimally invasive techniques, are further propelling market growth.

Market Segmentation

The sinus dilation devices market can be segmented by product, procedure type, patient type, and patient care setting.

Product: The market is classified into balloon dilation devices, endoscopes (sinuscopes, rhinoscopes), sinus stents/implants, and handheld instruments. The sinuscope segment is expected to lead the market due to its versatile application in providing clear images for diagnostic, therapeutic, and surgical procedures. This segment’s growth is fueled by product innovations and technological advancements.

Procedure Type: Sinus dilation procedures are either standalone or hybrid. The hybrid procedures involve a combination of balloon sinus dilation and traditional sinus surgery, offering benefits such as faster recovery and lower complication rates.

Patient Type: The market caters to both adult and pediatric patient types. An increase in the diagnosis of sinusitis among adults and children alike drives the need for sinus dilation devices.

Patient Care Setting: Sinus dilation procedures are carried out in various patient care settings, including hospitals and ambulatory surgery centers (ASCs) as well as ENT offices. Hospitals and ASCs are the primary settings due to the availability of advanced facilities and expertise.

Regional Insights

In North America, the US is the dominant market for sinus dilation devices. Factors such as the rising prevalence of sinusitis, favorable reimbursement scenarios, and the availability of advanced technologies drive the market’s growth in the region. Canada also contributes to the region’s growth with similar trends in healthcare infrastructure and patient demand.
Major Players

Prominent players in the sinus dilation devices market include:

  • Acclarent, Inc. (a subsidiary of Johnson & Johnson) – US
  • Olympus Corporation – Japan
  • Entellus Medical Inc. (a subsidiary of Stryker) – US
  • Medtronic Plc – Ireland
  • Smith & Nephew plc – UK
  • Intersect ENT, Inc. – US
  • SinuSys Corporation – US
  • InnAccel Pvt. Ltd – India
  • Optim LLC – US

These companies are focusing on developing innovative sinus dilation devices to cater to the growing demand. They invest in research and development to improve product offerings and expand their market share.

Request Free Sample Pages:

The sinus dilation devices market is set for sustained growth in the coming years, driven by an increasing prevalence of sinusitis, greater availability of reimbursements, and ongoing advancements in sinus dilation technology. As more patients seek minimally invasive treatments for sinusitis, demand for sinus dilation devices will continue to rise. With leading industry players investing in innovation and technology, the future of sinus dilation procedures looks promising.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441